<DOC>
	<DOCNO>NCT02063672</DOCNO>
	<brief_summary>To assess safety efficacy Lutonix Drug Coated Balloon treatment femoropopliteal artery ( SFA ) in-stent restenosis ( ISR ) .</brief_summary>
	<brief_title>Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty Treatment Femoropopliteal In-Stent Restenosis</brief_title>
	<detailed_description />
	<criteria>Key 1 . Male nonpregnant female ≥18 year age 2 . Rutherford Clinical Category 24 3 . Significant ( ≥ 50 % ) restenosis previous bare ( covered drugeluting ) nitinol stent ( ) femoropopliteal artery 4 . Lesion measure 4 18 cm 5 . Target vessel diameter ≥4 ≤6 mm able treat available device size matrix 6 . A patent inflow artery free significant lesion ( ≥50 % stenosis ) confirm angiography 7 . Successful cross predilatation target lesion guidewire 8 . At least one patent native outflow artery ankle , free significant ( ≥50 % ) stenosis confirm angiography previously ( plan ) revascularized 9 . No prior vascular surgical intervention within 2 week and/or plan 30 day protocol treatment Key 1 . Life expectancy &lt; 1 year 2 . Patient currently participate investigational drug device study previously enrol study NOTE : Enrollment another drug device clinical trial follow period allow 3 . History stroke within 3 month 4 . History MI , thrombolysis angina within 2 week enrollment 5 . Prior vascular surgery index limb , exception remote common femoral patch angioplasty separate least 2 cm target lesion 6 . Target lesion involve previously place covered stent drugeluting stent 7 . Grade 4 5 stent fracture ( malaligned component transaxial spiral configuration ) restenotic stent 8 . Inability take require study medication allergy contrast adequately manage pre postprocedure medication 9 . Known inadequate distal outflow ( &gt; 50 % stenosis distal popliteal and/or three tibial vessel ) , planned future treatment vascular disease distal target lesion 10 . Intended use adjunctive treatment modality ( i.e . laser , atherectomy , cryoplasty , scoring/cutting balloon , stent , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>